by The global creatinine test market is poised for significant growth in the coming years, driven by a combination of factors that underscore the importance of regular creatinine level monitoring. Creatinine, an essential substance in the body, can become potentially harmful when its levels rise excessively. This can lead to various complications, including fatigue, weakness, and dehydration, often without noticeable symptoms. Routine blood tests are crucial for detecting elevated creatinine levels, fueling the demand for creatinine tests worldwide.
The primary driver of the creatinine test market is the increasing prevalence of kidney diseases, with more than 10% of the global population affected by chronic kidney disease (CKD). With over 800 million individuals affected, continuous monitoring of creatinine levels and related components is essential, further boosting market growth.
Another significant contributor is the rising incidence of diabetes, a condition that can damage kidneys and lead to CKD. In 2021, approximately 537 million people aged 20 to 79 had diabetes, a number expected to reach 643 million by 2030 and 783 million by 2045. The connection between diabetes and CKD makes the creatinine test market pivotal in managing these conditions.
Urinary Tract Obstruction Segment Dominates
Within the creatinine test market, the urinary tract obstruction segment is projected to hold the highest revenue share. Factors such as lifestyle changes leading to kidney stones, rising cancer cases, postoperative infections in kidney transplant recipients, and the increased prevalence of hydronephrosis are driving this segments growth.
North America Leads, Asia Pacific Emerges as Fastest-Growing Region
North America is set to lead the creatinine test market, driven by significant healthcare spending, a high prevalence of renal diseases, and favorable reimbursement policies. In the United States alone, 15% of adults are projected to have CKD, further bolstering the regional market.
Meanwhile, the Asia Pacific region is poised to witness the fastest growth in the creatinine test market. Factors such as an increasing emphasis on early diagnosis, evolving technology, a substantial patient population, and government initiatives to combat chronic renal diseases are contributing to this growth. In India, for instance, two out of every three older adults suffer from chronic illnesses, making the markets expansion in the region inevitable.
Competitive Landscape
Key players in the creatinine test market are actively launching new products and forming strategic collaborations. Sysmex Corporation and Siemens Healthcare Diagnostics Inc., for instance, signed an exclusive distribution agreement to boost urinalysis business in North America. SphingoTec GmbH introduced a Point-of-Care (POC) test for Proenkephalin, enabling real-time monitoring of kidney function.
Prominent players in the creatinine test market include BioAssay Systems, Abcam plc, Arbor Assays, Thermo Fisher Scientific, Randox Laboratories Ltd., DiaSys Diagnostic Systems GmbH, Sentinel CH. SpA, Abbexa Ltd., MedTest Holdings Inc. (Pointe Scientific Inc.), and General Atomics Inc. (Diazyme Laboratories Inc.).
With the growing prevalence of kidney diseases and diabetes worldwide, the creatinine test market is on a trajectory of substantial expansion, playing a pivotal role in diagnosing and managing these conditions.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/creatinine-test-market
Our Blogs:
https://hackmd.io/@E4v1isUnROG4-prBVaQQGw/r1HtJRpR2
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of
services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
This press release first seen on Brilad
COMTEX_442085763/2840/2023-10-18T16:49:26
Julian Lopez is professor emeritus of finance, served as the founding academic affairs dean and founding chair of the finance department.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No journalist was involved in the writing and production of this article.